Status:
COMPLETED
Aerosol and Droplet Dispersion During Gastrointestinal Motility Investigations
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Aerosol Generation and Droplet Dispersion and Deposition During Naso-gastric Intubation for Gastrointestinal Motility Investigations
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To obtain more knowledge about the generation of aerosol and droplet dispersion and deposition during naso-gastric intubation for gastrointestinal motility investigations
Detailed Description
Health care workers (HCW) at the endoscopy unit are at constant occupational risk for many infectious diseases as they perform daily procedures that are believed to generate aerosol and droplets, whic...
Eligibility Criteria
Inclusion
- Aged \>18 years old;
- Male or female patients;
- Patients undergoing elective gastrointestinal motility investigations (MII-pH and HRiM);
- Negative PCR on nasopharyngeal swab 24 hours prior to the test;
- No anatomical deformity of nose and throat, no known diseases of nose and throat;
- Signed informed consent.
Exclusion
- Females who are pregnant or lactating;
- Use of anticoagulant medication;
- Known allergy to fluorescein.
Key Trial Info
Start Date :
July 23 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 9 2020
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04687488
Start Date
July 23 2020
End Date
November 9 2020
Last Update
December 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TARGID
Leuven, Vlaams-Brabant, Belgium